US OptionsDetailed Quotes
QTRX250117C10000
- 0.05
- 0.000.00%
15min DelayClose Jan 17 16:00 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume757 Open Interest10.00Strike Price0.00Turnover2228.40%IV0.30%PremiumJan 17, 2025Expiry Date0.02Intrinsic Value100Multiplier-5DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.1185Delta0.2208Gamma200.40Leverage Ratio-11.5133Theta0.0000Rho23.74Eff Leverage0.0001Vega
Quanterix Stock Discussion
Sign in to post a comment
$Quanterix (QTRX.US)$ $Akoya Biosciences (AKYA.US)$ Reuters· 1 min ago
Quanterix Is Close to All-Stock Deal for Akoya Bioscience - Bloomberg News
Quanterix Is Close to All-Stock Deal for Akoya Bioscience - Bloomberg News
2
2
The insider transactions over the last year suggest optimism about the company's future. The level of insider ownership indicates a reasonable degree of alignment with common shareholders.
Gainers:
In reaction to earnings/guidance:
• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $Aspen Technology (AZPN.US)$ +5.4%, $AAON Inc (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4...
In reaction to earnings/guidance:
• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $Aspen Technology (AZPN.US)$ +5.4%, $AAON Inc (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4...
24
11
Gainers
• $MillerKnoll (MLKN.US)$ +12.4%, $BioNTech (BNTX.US)$ +7.4%, $Lululemon Athletica (LULU.US)$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics (ADGI.US)$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
• $MillerKnoll (MLKN.US)$ +12.4%, $BioNTech (BNTX.US)$ +7.4%, $Lululemon Athletica (LULU.US)$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics (ADGI.US)$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
18
8
2
$Quanterix (QTRX.US)$ beat eps. low liquidity could see a 7-14.00 increase
1
1
No comment yet
152398576 : your update made me a buck
Trytosaveabit OP 152398576 : That’s awesome congrats
! But you made the trade! I just pointed in the proper direction for a possible move! Hehehe